Corcept Therapeutics CORT
NASDAQ CORT
$116.45 +4.35 (+3.88%)
At close: Oct 20, 2026 · 4:00 PM EDT

Corcept Therapeutics (CORT) Interest Expenses (2011 - 2017)

Updated

Corcept Therapeutics (CORT) posted Interest Expenses of $98,000 for Q2 2017, down 81.5% from $531,000 a year earlier and down 56.4% from the prior quarter.

Analysis

Corcept Therapeutics (CORT) Interest Expenses (2011 - 2017) Analysis & Trends

For the trailing twelve months through Jun 30, 2017, Interest Expenses at Corcept Therapeutics was $1.22 million, down 51.9% year-over-year; for FY2016, it was $2.04 million, down 31.2% from FY2015.

  • Annual Interest Expenses has declined for three consecutive years, though with a five-year compound annual growth rate of 141.2% (FY2011 to FY2016).
  • In prior years, Corcept Therapeutics' Interest Expenses was $2.97 million in FY2015 (-21.2%), $3.76 million in FY2014 (-16.6%), $4.52 million in FY2013 (+154.2%) and $1.78 million in FY2012.
  • The Q2 2017 figure stands as the lowest quarterly Interest Expenses since Q2 2012.
  • On a year-over-year basis, Interest Expenses has declined in each of the last 15 quarters, with an average decline of 38.6% over the last eight quarters.
  • The strongest year-over-year quarter for Interest Expenses in the past five years was Q3 2013, with growth of 87.5%; the weakest was Q2 2017, with a decline of 81.5%.
  • According to Business Quant data, Interest Expenses for the three prior quarters was $225,000 (Q1 2017), $410,000 (Q4 2016) and $487,000 (Q3 2016).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn -
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 281.00 Mn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 435.00 Mn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 247.00 Mn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Corcept Therapeutics 12.27 Bn 10.83 Bn 252.09 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 98,000.00
Mar 31, 2017 225,000.00
Dec 31, 2016 410,000.00
Sep 30, 2016 487,000.00
Jun 30, 2016 531,000.00
Mar 31, 2016 611,000.00
Dec 31, 2015 692,000.00
Sep 30, 2015 703,000.00
Jun 30, 2015 770,000.00
Mar 31, 2015 800,000.00
Dec 31, 2014 818,000.00
Sep 30, 2014 903,000.00
Jun 30, 2014 971,000.00
Mar 31, 2014 1.07 Mn
Dec 31, 2013 1.09 Mn
Sep 30, 2013 1.17 Mn
Jun 30, 2013 1.11 Mn
Mar 31, 2013 1.14 Mn
Dec 31, 2012 1.14 Mn
Sep 30, 2012 622,000.00
API Access

Corcept Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=CORT&period=max&api_key=YOUR_API_KEY